Drug
Arct 2304
Arct 2304: highest development phase Phase 1/2, developed by Arcturus Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Arcturus Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARCT-2304 NCT06602531 | Phase 1/2 | Influenza, Human |
Latest
No recent events.
Follow Arct 2304 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.